Article info
PDFAetiology
Systematic review with meta-analysis
Stimulant medication for ADHD not associated with subsequent substance use disorders
- Correspondence to: Dr Paula D Riggs, Department of Psychiatry, Division of Substance Dependence, University of Colorado School of Medicine, 12469 East 17th Place, Building 400, Aurora, Denver, CO 80045, USA; paula.riggs{at}ucdenver.edu
Citation
Stimulant medication for ADHD not associated with subsequent substance use disorders
Publication history
- First published November 26, 2013.
Online issue publication
September 25, 2019
Article Versions
- Previous version (25 September 2019).
- Previous version (25 September 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions